Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real‐life study from European Myeloma Network ( EMN ) Italy
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70751 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Gregorio Barilà und 48 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, San Bortolo Hospital, Vicenza, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Lenalidomide, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The extensive use of lenalidomide (Len) in the first‐line treatment of multiple myeloma (MM) has resulted in an increased frequency of patients who have been exposed or are refractory to Len (Len‐R) at first relapse. However, the outcome of Len‐R patients treated at first relapse after autologous haematopoietic stem cell transplantation (AHSCT) remains unclear. The aim of this real‐life study is to evaluate the effectiveness of the regimens licensed in Italy and used in a cohort of patients who relapsed during Len maintenance after AHSCT. We collected 306 patients with these features. Considering the different regimens used, most patients received isatuximab–carfilzomib–dexamethasone (Isa‐KD) (45.4%) followed by daratumumab–pomalidomide–dexamethasone (D‐PD) (19.3%) and daratumumab–bortezomib–dexamethasone (D‐VD) (12.4%). Overall, a reduced progression‐free survival (PFS) and overall survival (OS) were observed in patients with high‐risk disease features at relapse, including high lactate dehydrogenase (LDH) ( p = 0.0003 and p < 0.0001), International Staging System (ISS) ≥2 ( p < 0.0001 and p < 0.0001) and early relapse (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology Unit, San Bortolo Hospital, Vicenza, Italy.
- Clinical Research Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
- Department of Medicine (DIMED), Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
- Department of Medicine and Sciences of Aging, "G d'Annunzio" University, Chieti, Italy.
- Hematology Unit, Santo Spirito Hospital, Pescara, Italy.
- Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
ORCID-Profile: Gregorio Barilà, Angela Grassi, Carmine Liberatore, Edoardo Olivari, Francesca Fazio, Sonia Morè, Emanuele Favero, Claudio Salvatore Cartia, Nicola Sgherza, Concetta Conticello, Roberto Mina, Giuseppe Mele, Massimo Gentile, Anna Furlan, Maria Livia Del Giudice, Ombretta Annibali, Bernardo Rossini, Edoardo Scomazzon, Marco Talarico, Enrica Antonia Martino, Laura Paris, Roberta Della Pepa, Giuseppe Pietrantuono, Antonia Cagnetta, Lorenzo De Paoli, Gabriele Buda, Elisabetta Antonioli, Alberto Tosetto, Pellegrino Musto, Elena Zamagni, Silvia Mangiacavalli, Renato Zambello, Massimo Offidani
Zitieren
APA
Barilà, G., Grassi, A., Ruocco, V., Liberatore, C., Olivari, E., Tinelli, M., Fazio, F., Morè, S., Favero, E., Cartia, C. S., Sgherza, N., Conticello, C., Mina, R., Gherardini, M., Mele, G., Gentile, M., Furlan, A., Febbo, M. A., Del Giudice, M. L., …, & Petrucci, M. T. (2026). Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real‐life study from European Myeloma Network ( EMN ) Italy. British Journal of Haematology. https://doi.org/10.1111/bjh.70751
Vancouver
Barilà G, Grassi A, Ruocco V, Liberatore C, Olivari E, Tinelli M, et al. Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real‐life study from European Myeloma Network ( EMN ) Italy. British Journal of Haematology. 2026. doi:10.1111/bjh.70751
BibTeX
@article{Baril2026,
author = {Barilà, Gregorio and Grassi, Angela and Ruocco, Valeria and Liberatore, Carmine and Olivari, Edoardo and Tinelli, Martina and Fazio, Francesca and Morè, Sonia and Favero, Emanuele and Cartia, Claudio Salvatore and Sgherza, Nicola and Conticello, Concetta and Mina, Roberto and Gherardini, Martina and Mele, Giuseppe and Gentile, Massimo and Furlan, Anna and Febbo, Massimiliano Arangio and Del Giudice, Maria Livia and Annibali, Ombretta and Rossini, Bernardo and Scomazzon, Edoardo and Talarico, Marco and Martino, Enrica Antonia and De Magistris, Claudio and Fioritoni, Francesca and Cafro, Anna Maria and Paris, Laura and Pezzatti, Sara and Della Pepa, Roberta and Boggione, Paola and Pietrantuono, Giuseppe and Tomarchio, Valeria and Vassallo, Francesco and Pioltelli, Maria Luisa and Pisani, Francesco and Cagnetta, Antonia and De Paoli, Lorenzo and Buda, Gabriele and Antonioli, Elisabetta and Galli, Monica and Tosetto, Alberto and Musto, Pellegrino and Zamagni, Elena and Patriarca, Francesca and Mangiacavalli, Silvia and Zambello, Renato and Offidani, Massimo and Petrucci, Maria Teresa},
title = {Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real‐life study from European Myeloma Network ( EMN ) Italy},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70751}
}
EUVIMED